type here...
type here...
START FREE TRIAL

M&A

Technology & AIHealthcareM&AConsumer & RetailEnergyMiscellaneous

Did Apple’s MotionVFX Acquisition Just DEEPEN Its Creator Ecosystem Moat?

M&A Ishan Majumdar -
Apple (NASDAQ:AAPL) has been busy giving investors plenty to chew on. The company just posted a record quarter, with revenue up 16% year over...

Is Meta’s Moltbook Deal About Social Media … Or The Future Of AI Agents?

M&A Ishan Majumdar -
Recent developments around Meta Platforms (NASDAQ:META) suggest the company is continuing its aggressive push into artificial intelligence infrastructure and agent-based computing. The company recently...
spot_imgspot_img

Agilent’s $950M Biocare Acquisition Could Unlock A Powerful Recurring Revenue Flywheel

M&A Ishan Majumdar -
The diagnostics and life sciences equipment industry rarely stands still. But recent developments around Agilent Technologies (NYSE:A) have drawn...

Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!

M&A Ishan M. -
It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is...

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

M&A Ishan Majumdar -
Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline add-on in a year already defined...

Is Apple Outflanking Meta With This Q.AI Move?

M&A Ishan Majumdar -
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

M&A Ishan Majumdar -
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

Healthcare Ishan Majumdar -
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
Load more

Did Apple’s MotionVFX Acquisition Just DEEPEN Its Creator Ecosystem Moat?

M&A Ishan Majumdar -
Apple (NASDAQ:AAPL) has been busy giving investors plenty to chew on. The company just posted a record quarter, with...

Is Meta’s Moltbook Deal About Social Media … Or The Future Of AI Agents?

M&A Ishan Majumdar -
Recent developments around Meta Platforms (NASDAQ:META) suggest the company is continuing its aggressive push into artificial intelligence infrastructure and...

Agilent’s $950M Biocare Acquisition Could Unlock A Powerful Recurring Revenue Flywheel

M&A Ishan Majumdar -
The diagnostics and life sciences equipment industry rarely stands still. But recent developments around Agilent Technologies (NYSE:A) have drawn...

Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!

M&A Ishan M. -
It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is...

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

M&A Ishan Majumdar -
Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline add-on in a year already defined...

Is Apple Outflanking Meta With This Q.AI Move?

M&A Ishan Majumdar -
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

M&A Ishan Majumdar -
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

Healthcare Ishan Majumdar -
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

APi Group CertaSite Acquisition Sparks Investor Debate

Industrials Ishan Majumdar -
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...

Netflix Warner Bros Acquisition Could Change Streaming Forever

M&A Ishan Majumdar -
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...

Paramount Warner Bros Merger vs. Netflix Explained!

M&A Ishan Majumdar -
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

M&A Ishan Majumdar -
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Meta & Nebius Show Why AI’s Biggest Constraint Isn’t Chips!

0
The artificial intelligence boom has created a new kind...

Did Markets Misread Intuit’s Position In The AI Era?

0
Markets love a good villain. Right now, artificial intelligence...

Did Apple’s MotionVFX Acquisition Just DEEPEN Its Creator Ecosystem Moat?

0
Apple (NASDAQ:AAPL) has been busy giving investors plenty to...

Trump Wants Allies’ Help For Hormuz — THESE Stocks May React Next!

0
The Iran war has turned a narrow shipping corridor...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.